Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,695 | -11,330 | -15,198 | -15,080 | -9,764 |
| Depreciation Amortization | 1,573 | 1,608 | 1,698 | 887 | 1,023 |
| Accounts receivable | 446 | -1,967 | -1,208 | -67 | -1,624 |
| Accounts payable and accrued liabilities | -137 | -288 | -1,307 | -102 | 1,612 |
| Other Working Capital | -2,038 | -2,525 | -583 | -2,580 | -930 |
| Other Operating Activity | 50 | 4,656 | 4,544 | 2,254 | -1,473 |
| Operating Cash Flow | $-11,801 | $-9,846 | $-12,054 | $-14,688 | $-11,156 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -188 | -37 | N/A | -175 | -59 |
| Net Acquisitions | N/A | N/A | -157 | -5,000 | N/A |
| Investing Cash Flow | $-188 | $-37 | $-157 | $-5,175 | $-59 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,925 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,250 | -1,250 | -313 | N/A | N/A |
| Common Stock Issued | 7,954 | 9,019 | 661 | N/A | 38,712 |
| Other Financing Activity | -2,000 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $6,629 | $7,769 | $348 | $N/A | $38,712 |
| Exchange Rate Effect | 36 | -31 | -24 | -18 | 47 |
| Beginning Cash Position | 6,493 | 8,638 | 20,525 | 40,406 | 12,862 |
| End Cash Position | 1,169 | 6,493 | 8,638 | 20,525 | 40,406 |
| Net Cash Flow | $-5,324 | $-2,145 | $-11,887 | $-19,881 | $27,544 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,801 | -9,846 | -12,054 | -14,688 | -11,156 |
| Capital Expenditure | -188 | -37 | N/A | -194 | -59 |
| Free Cash Flow | -11,989 | -9,883 | -12,054 | -14,882 | -11,215 |